Vincent Rajkumar, Oncologist at Mayo Clinic specializing in Myeloma, Amyloidosis, Macroglobulinemia, MGUS, and Related Disorders, and Editor-in-Chief of the Blood Cancer Journal, on X:
“My 2026 Update on Diagnosis, Risk Stratification, and Treatment of Myeloma is out!
It’s current including all recent advances in immunotherapy. Managed to squeeze in iberdomide approval from 6 days ago! Bookmark!”
Title: Multiple Myeloma: 2026 Update on Diagnosis, Risk-Stratification and Management
Author: S. Vincent Rajkumar
You can also read: FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR
